Gene Editing Will Change Medicine—and Maybe Health Investing Too

[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…

FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs

[ad_1] Health Agency places more holds on trials to protect patients, ensure studies are designed properly, Wall Street Journal review finds [ad_2] Source link

Drug Prices Reach New High—in the Millions

[ad_1] Several new drugs, most of them gene therapies, promise one-time treatments, but their price tags will test the health-insurance system. [ad_2] Source link